The Transaxillary Access for Minimally Invasive Valve Surgery Is Safe and Effective in Selected Patients With Native Valve Endocarditis
Journal of Cardiac Surgery · 2026-01 · 2026 (1)
DOI: 10.1155/jocs/5460274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Surgery, online erschienen am 25.02.2026. Verfasst von Asen Petrov und 8 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Minimally invasive surgery for endocarditis reflects an emerging advancement in surgical therapy. Transaxillary access is a novel approach, with little current data on its safety and efficacy in these patients. This study reports outcomes of a transaxillary access cohort in aortic and mitral endocarditis compared to a full‐sternotomy cohort.
Methods
All consecutive patients undergoing surgery for native infective endocarditis from 2021 to 2024 at our facility were enrolled. Exclusion criteria were redo procedures, right‐sided endocarditis, and concomitant bypass surgery. The patients fulfilling the inclusion criteria ( n = 179/316; 56.7%) were divided into a transaxillary cohort ( n = 81) and a sternotomy cohort ( n = 98). After 1:1 propensity matching, 122 patients remained, with 61 in each cohort.
Results
Patient age was 63.3 years vs. 61.5 years, p = 0.36, in the transaxillary and sternotomy cohorts. Clinical baselines were well balanced between cohorts. Minimally invasive multivalve operations comprised n = 3 (4.9%) vs. n = 8 (13.9%), p = 0.21. The distribution of aortic ( n = 42, 68.9% vs. n = 44, 72.1%, p = 0.84) and mitral valve surgery ( n = 23, 37.7% vs. n = 27, 44.3%, p = 0.58) was similar. Except for intensive care unit stay (transaxillary 3.0 days vs. sternotomy 6.0 days, p < 0.01) and frequent renal failure in sternotomy patients, there were no significant differences in postoperative course. Transaxillary patients had comparable 30‐day (91.8% vs. 85.2%; p = 0.40) and long‐term survival at 3 years (89.1% vs. 73.9%; p = 0.052). Recurrent endocarditis rates did not differ ( n = 4, 6.6% vs. n = 5, 8.2%, p = 1.00).
Conclusions
In selected patients, minimally invasive surgery using the transaxillary access achieved comparable survival with full sternotomy without sacrificing procedural safety. A comprehensive diagnostic approach is essential to exclude patients needing extensive reconstructive surgery.
Zitieren
APA
Petrov, A., Taghizadeh-Waghefi, A., Kolaschnik, M., Arzt, S., Alexiou, K., Tugtekin, S., Matschke, K., Kappert, U., & Wilbring, M. (2026). The Transaxillary Access for Minimally Invasive Valve Surgery Is Safe and Effective in Selected Patients With Native Valve Endocarditis. Journal of Cardiac Surgery, 2026(1). https://doi.org/10.1155/jocs/5460274
Vancouver
Petrov A, Taghizadeh-Waghefi A, Kolaschnik M, Arzt S, Alexiou K, Tugtekin S, et al. The Transaxillary Access for Minimally Invasive Valve Surgery Is Safe and Effective in Selected Patients With Native Valve Endocarditis. Journal of Cardiac Surgery. 2026;2026(1). doi:10.1155/jocs/5460274
BibTeX
@article{Petrov2026,
author = {Petrov, Asen and Taghizadeh-Waghefi, Ali and Kolaschnik, Marielle and Arzt, Sebastian and Alexiou, Konstantin and Tugtekin, Sems-Malte and Matschke, Klaus and Kappert, Utz and Wilbring, Manuel},
title = {The Transaxillary Access for Minimally Invasive Valve Surgery Is Safe and Effective in Selected Patients With Native Valve Endocarditis},
journal = {Journal of Cardiac Surgery},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jocs/5460274}
}
EUVIMED